Integrated Approach Lowers Specialty Spend for Employers and Plan Members
VIDEO (8:38)
December 8, 2020
The COVID-19 pandemic has exacerbated existing challenges for many, including employers trying to provide sustainable, cost-effective benefits to their workforce. Combined with price increases for specialty drugs, this is putting a significant strain on employers already facing tough decisions about benefits.
In this video, Prem Shah, PharmD, Executive Vice President, Specialty and Product Innovation, CVS Health, discusses how to control specialty drug costs while enhancing clinically appropriate care for members.
Want to learn more about how to address growing specialty drug spend? Ask Us
VIDEO (8:38)
December 8, 2020
Image source: Licensed from Getty Images, 2020.